Expression profiles frame the promoter specificity dilemma of the ETS family of transcription factors
Open accessThe DOI matches its Crossref record; 86 of the 89 references it cites were found in a registry or an index.
Abstract
Sequence-specific DNA binding proteins that function as transcription factors are frequently encoded by gene families. Such proteins display highly conserved DNA binding properties, yet are expected to retain promoter selectivity. In this report we investigate this problem using the ets gene family, a group of metazoan genes whose members regulate cell growth and differentiation and are mutated in human cancers. We tested whether the level of mRNA can serve as a specificity determinant. The mRNA levels of the 27 paralogous human ets genes were measured in 23 tissues and cell lines. Real-time RT-PCR provided accurate measurement of absolute mRNA levels for each gene down to one copy per cell. Surprisingly, at least 16 paralogs were expressed in each cell sample and over half were expressed ubiquitously. Tissues and complementary cell lines showed similar expression patterns, indicating that tissue complexity was not a limitation. There was no unique, highly expressed gene for each cell type. Instead, one of only eight ets genes showed the highest expression in all samples. DNA binding studies illustrate both overlapping and unique specificities for ubiquitous ETS proteins. These findings establish the parameters of the promoter specificity dilemma within the ets family of transcription factors.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“In any particular cell type, 14 to 25 family members are coexpressed.”
From Genomic and biochemical insights into the specificity of ETS transcription factors (2011) · cites this paper as [34]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“Half of the family members are ubiquitously expressed in all cell types tested.”
From Genomic and biochemical insights into the specificity of ETS transcription factors (2011) · cites this paper as [34]
In the citing paper
“In spite of the biological and biochemical evidence that different ETS proteins can execute diverse roles, an extensive overlap in the expression of various family members is found in many human tissues.”
From Genomic and biochemical insights into the specificity of ETS transcription factors (2011) · cites this paper as [34]
In the citing paper
“Expression profiles in transformed cell lines show strong similarity to those in matching normal tissues, although exceptions are worth noting.”
From Genomic and biochemical insights into the specificity of ETS transcription factors (2011) · cites this paper as [34]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Quantification of mRNA using real-time reverse transcription PCR (RT-PCR): trends and problems
Bustin, S. (2002) · Journal of Molecular Endocrinology · doi:10.1677/jme.0.0290023 · Cited by 2,546
Requirement of transcription factor PU.1 in the development of multiple hematopoietic lineages
Scott, E. W., Simon, M. C., Anastasi, J., & Singh, H. (1994) · Science · doi:10.1126/science.8079170 · Cited by 1,532
Gene Expression Profiles in Normal and Cancer Cells
Zhang, L., Zhou, W., Velculescu, V. E., Kern, S. E., Hruban, R. H., Hamilton, S. R., Vogelstein, B., & Kinzler, K. W. (1997) · Science · doi:10.1126/science.276.5316.1268 · Cited by 1,184
Golub, T. R., Barker, G. F., Lovett, M., & Gilliland, D. G. (1994) · Cell · doi:10.1016/0092-8674(94)90322-0 · Cited by 1,155
Targeted disruption of the PU.1 gene results in multiple hematopoietic abnormalities
McKercher, S. R., Torbett, B. E., Anderson, K. L., Henkel, G. W., Vestal, D. J., Baribault, H., Klemsz, M., Feeney, A. J., Wu, G. E., Paige, C. J., et al. (1996) · The EMBO Journal · doi:10.1002/j.1460-2075.1996.tb00949.x · Cited by 1,130 · cited 1×
“1 HL-60, lung Spleen, testis (30,31,79) Embryonic lethal, no myeloid or lymphoid differentiation (80,81) SPIB Raji, Spleen Lymphocytes-particularly mature B cells (31) B-cell defects (82) SPIC Spleen Spleen and lymph nodes (32) E1AF HCT116, HeLa, HepG2, HMEC, PC3, HL-60 Tissues in branching morphogenesis (83); Brain,…”
The ETS-domain transcription factor family
Sharrocks, A. D. (2001) · Nature Reviews Molecular Cell Biology · doi:10.1038/35099076 · Cited by 1,086
The macrophage and B cell-specific transcription factor PU.1 is related to the ets oncogene
Klemsz, M. J., McKercher, S. R., Celada, A., Van Beveren, C., & Maki, R. A. (1990) · Cell · doi:10.1016/0092-8674(90)90219-5 · Cited by 954
Forkhead Transcription Factors: Key Players in Development and Metabolism
Carlsson, P., & Mahlapuu, M. (2002) · Developmental Biology · doi:10.1006/dbio.2002.0780 · Cited by 840
Ternary complex factors: growth factor regulated transcriptional activators
Treisman, R. (1994) · Current Opinion in Genetics & Development · doi:10.1016/0959-437x(94)90097-3 · Cited by 676
Takahashi, Y., Rayman, J. B., & Dynlacht, B. D. (2000) · Genes & Development · doi:10.1101/gad.14.7.804 · Cited by 621
Research works printed but not linked: 3
- [2]2. Graves,B.J. and Petersen,J.M. (1998) In Woude,G.V. and Klein,G. (eds), Advances in Cancer Research . Academic Press, San Diego, Vol. 75, pp. 1-55.
- [17]17. Rozen,S. and Skaletsky,H.J. (2000) In Krawetz,S. and Misener,S. (eds), Bioinformatics Methods and Protocols: Methods in Molecular Biology . Humana Press, Totowa, NJ, pp. 365-386.
- [22]22. Gunther,C.V. (1994) Regulation of Moloney Murine Retrovirus Transcription by the ETS gene family. PhD Thesis, University of Utah, UT, USA.
Cited by
Genome-wide analysis of ETS-family DNA-binding in vitro and in vivo
Wei, G., Badis, G., Berger, M. F., Kivioja, T., Palin, K., Enge, M., Bonke, M., Jolma, A., Varjosalo, M., Gehrke, A. R., et al. (2010) · The EMBO Journal · doi:10.1038/emboj.2010.106 · Cited by 568
Genomic and biochemical insights into the specificity of ETS transcription factors
Hollenhorst, P. C., McIntosh, L. P., & Graves, B. J. (2011) · Annual Review of Biochemistry · doi:10.1146/annurev.biochem.79.081507.103945 · Cited by 490
Self-citationETS transcription factors and their emerging roles in human cancer
Seth, A., & Watson, D. K. (2005) · European Journal of Cancer · doi:10.1016/j.ejca.2005.08.013 · Cited by 469
Transcriptional Control of Endothelial Cell Development
De Val, S., & Black, B. L. (2009) · Developmental Cell · doi:10.1016/j.devcel.2009.01.014 · Cited by 346
“It will be interesting to determine whether this is a general mechanism for endothelial gene activation and if Ets proteins function combinatorially with factors other than FoxC proteins by cobinding DNA through composite sites, as has been proposed (De Val et al., 2008; Hollenhorst et al., 2007).”
BackgroundCombinatorial Regulation of Endothelial Gene Expression by Ets and Forkhead Transcription Factors
De Val, S., Chi, N. C., Meadows, S. M., Minovitsky, S., Anderson, J. P., Harris, I. S., Ehlers, M. L., Agarwal, P., Visel, A., Xu, S.-M., et al. (2008) · Cell · doi:10.1016/j.cell.2008.10.049 · Cited by 343
Microsatellites as EWS/FLI response elements in Ewing's sarcoma
Gangwal, K., Sankar, S., Hollenhorst, P. C., Kinsey, M., Haroldsen, S. C., Shah, A. A., Boucher, K. M., Watkins, W. S., Jorde, L. B., Graves, B. J., et al. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0801073105 · Cited by 297
Self-citationHollenhorst, P. C., Shah, A. A., Hopkins, C., & Graves, B. J. (2007) · Genes & Development · doi:10.1101/gad.1561707 · Cited by 290
“Interestingly, this predicted specificity must exist in an environment in which multiple ETS proteins are present, because more than half of the 27 human ETS genes are expressed in any particular cell type (Galang et al. 2004; Hollenhorst et al. 2004).”
BackgroundMethodSelf-citationTranscription factor Erg regulates angiogenesis and endothelial apoptosis through VE-cadherin
Birdsey, G. M., Dryden, N. H., Amsellem, V., Gebhardt, F., Sahnan, K., Haskard, D. O., Dejana, E., Mason, J. C., & Randi, A. M. (2008) · Blood · doi:10.1182/blood-2007-08-105346 · Cited by 268
ETV1, 4 and 5: An oncogenic subfamily of ETS transcription factors
Oh, S., Shin, S., & Janknecht, R. (2012) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2012.02.002 · Cited by 249
DNA Specificity Determinants Associate with Distinct Transcription Factor Functions
Hollenhorst, P. C., Chandler, K. J., Poulsen, R. L., Johnson, W. E., Speck, N. A., & Graves, B. J. (2009) · PLoS Genetics · doi:10.1371/journal.pgen.1000778 · Cited by 198
“ETS family members are extensively coexpressed [8,9].”
Self-citationThe role of the transcription factor Ets1 in carcinoma
Dittmer, J. (2015) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2015.09.010 · Cited by 212
Szuhai, K., IJszenga, M., de Jong, D., Karseladze, A., Tanke, H. J., & Hogendoorn, P. C. W. (2009) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-08-2184 · Cited by 204
Elk-1 a Transcription Factor with Multiple Facets in the Brain
Besnard, A., Galan-Rodriguez, B., Vanhoutte, P., & Caboche, J. (2011) · Frontiers in Neuroscience · doi:10.3389/fnins.2011.00035 · Cited by 195
Kron, K. J., Murison, A., Zhou, S., Huang, V., Yamaguchi, T. N., Shiah, Y.-J., Fraser, M., van der Kwast, T., Boutros, P. C., Bristow, R. G., et al. (2017) · Nature Genetics · doi:10.1038/ng.3930 · Cited by 187
EWS–ETS oncoproteins: The linchpins of Ewing tumors
Janknecht, R. (2005) · Gene · doi:10.1016/j.gene.2005.08.007 · Cited by 173
The molecular regulation of arteriovenous specification and maintenance
Fish, J. E., & Wythe, J. D. (2015) · Developmental Dynamics · doi:10.1002/dvdy.24252 · Cited by 164
Oncogenic ETS proteins mimic activated RAS/MAPK signaling in prostate cells
Hollenhorst, P. C., Ferris, M. W., Hull, M. A., Chae, H., Kim, S., & Graves, B. J. (2011) · Genes & Development · doi:10.1101/gad.17546311 · Cited by 154
Self-citationVander Kooi, B. T., Onuma, H., Oeser, J. K., Svitek, C. A., Allen, S. R., Vander Kooi, C. W., Chazin, W. J., & O’Brien, R. M. (2005) · Molecular Endocrinology · doi:10.1210/me.2004-0497 · Cited by 153
Shah, A. V., Birdsey, G. M., & RANDI, A. M. (2016) · Vascular Pharmacology · doi:10.1016/j.vph.2016.05.003 · Cited by 168
Direct Reprogramming of Human Dermal Fibroblasts Into Endothelial Cells Using ER71/ETV2
Lee, S.-H., Park, C., Han, J.-W., Kim, J., Cho, K.-W., Kim, E., Kim, S., Lee, S.-J., Oh, S.-Y., Tanaka, Y., et al. (2016) · Circulation Research · doi:10.1161/circresaha.116.309833 · Cited by 127
Molecular mechanisms of ETS transcription factor-mediated tumorigenesis
Kar, A., & Gutierrez‐Hartmann, A. (2013) · Critical Reviews in Biochemistry and Molecular Biology · doi:10.3109/10409238.2013.838202 · Cited by 169
Transcriptional Regulation of Endothelial Cell and Vascular Development
Park, C., Kim, T., & Malik, A. B. (2013) · Circulation Research · doi:10.1161/circresaha.113.301078 · Cited by 159
Palii, C. G., Perez-Iratxeta, C., Yao, Z., Cao, Y., Dai, F., Davison, J., Atkins, H., Allan, D., Dilworth, F. J., Gentleman, R., et al. (2011) · The EMBO Journal · doi:10.1038/emboj.2010.342 · Cited by 140
ETS transcription factors in endocrine systems
Gutierrez‐Hartmann, A., Duval, D. L., & Bradford, A. P. (2007) · Trends in Endocrinology and Metabolism · doi:10.1016/j.tem.2007.03.002 · Cited by 148
Foxs and Ets in the transcriptional regulation of endothelial cell differentiation and angiogenesis
Dejana, E., Taddei, A., & RANDI, A. M. (2007) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2007.05.003 · Cited by 153
A c-Rel subdomain responsible for enhanced DNA-binding affinity and selective gene activation
Sanjabi, S., Williams, K. J., Saccani, S., Zhou, L., Hoffmann, A., Ghosh, G., Gerondakis, S., Natoli, G., & Smale, S. T. (2005) · Genes & Development · doi:10.1101/gad.1329805 · Cited by 132
Boros, J., Donaldson, I. J., O'Donnell, A., Odrowaz, Z. A., Zeef, L., Lupien, M., Meyer, C. A., Liu, X. S., Brown, M., & Sharrocks, A. D. (2009) · Genome Research · doi:10.1101/gr.093047.109 · Cited by 127
“There are 27 different ETS-domain transcription factors expressed in mammalian cells, and their relative expression differs according to cell type (Hollenhorst et al. 2004).”
BackgroundDNA motifs in human and mouse proximal promoters predict tissue-specific expression
Smith, A. D., Sumazin, P., Xuan, Z., & Zhang, M. Q. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0508169103 · Cited by 125
ETS1 is a genome-wide effector of RAS/ERK signaling in epithelial cells
Plotnik, J. P., Budka, J. A., Ferris, M. W., & Hollenhorst, P. C. (2014) · Nucleic Acids Research · doi:10.1093/nar/gku929 · Cited by 127
Self-citationRizzo, F. M., Fernandez-Serra, M., Squarzoni, P., Archimandritis, A., & Arnone, M. I. (2006) · Developmental Biology · doi:10.1016/j.ydbio.2006.08.012 · Cited by 126
Sans, C. L., Satterwhite, D. J., Stoltzman, C. A., Breen, K. T., & Ayer, D. E. (2006) · Molecular and Cellular Biology · doi:10.1128/mcb.00657-05 · Cited by 117
Direct Conversion of Adult Skin Fibroblasts to Endothelial Cells by Defined Factors
Han, J., Chang, S.-H., Cho, H.-J., Choi, S.-B., Ahn, H., Lee, J., Jeong, H., Youn, S., Lee, H.-J., Kwon, Y., et al. (2014) · Circulation · doi:10.1161/circulationaha.113.007727 · Cited by 121
Future treatments in systemic sclerosis
ASANO, Y. (2010) · The Journal of Dermatology · doi:10.1111/j.1346-8138.2009.00758.x · Cited by 108
Nakerakanti, S. S., Kapanadze, B., Yamasaki, M., Markiewicz, M., & Trojanowska, M. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m600466200 · Cited by 109
Transcription factor Ets-1 in cytokine and chemokine gene regulation
Russell, L., & Garrett‐Sinha, L. A. (2010) · Cytokine · doi:10.1016/j.cyto.2010.03.006 · Cited by 113
Understanding the Role of ETS-Mediated Gene Regulation in Complex Biological Processes
Findlay, V. J., LaRue, A. C., Turner, D. P., Watson, P. M., & Watson, D. K. (2013) · Advances in cancer research · doi:10.1016/b978-0-12-407190-2.00001-0 · Cited by 125
Regulation of endothelial cell development by ETS transcription factors
Meadows, S. M., Myers, C. T., & Krieg, P. A. (2011) · Seminars in Cell and Developmental Biology · doi:10.1016/j.semcdb.2011.09.009 · Cited by 107
Asano, Y., Czuwara, J., & Trojanowska, M. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m703907200 · Cited by 104
An integrated ChIP-seq analysis platform with customizable workflows
Giannopoulou, E. G., & Elemento, O. (2011) · BMC Bioinformatics · doi:10.1186/1471-2105-12-277 · Cited by 92
The L6 Protein TM4SF1 Is Critical for Endothelial Cell Function and Tumor Angiogenesis
Shih, S., Zukauskas, A., Li, D., Liu, G., Ang, L., Nagy, J. A., Brown, L. F., & Dvorak, H. F. (2009) · Cancer Research · doi:10.1158/0008-5472.can-08-4886 · Cited by 89
Aisa, Z., Wen, J., Yu, H., Chen, X., Xu, L., Ma, X., & Zhang, B. (2023) · Congenital Heart Disease · doi:10.32604/chd.2023.047689 · Cited by 99
Endothelial Cell Development and Its Application to Regenerative Medicine
Qiu, J., & Hirschi, K. K. (2019) · Circulation Research · doi:10.1161/circresaha.119.311405 · Cited by 89
Heo, S., Choi, Y., Ryoo, H., & Cho, J. (2010) · Journal of Cellular Physiology · doi:10.1002/jcp.22175 · Cited by 95
Finka, A., Sood, V., Quadroni, M., Rios, P. D. L., & Goloubinoff, P. (2015) · Cell Stress and Chaperones · doi:10.1007/s12192-015-0583-2 · Cited by 90
Regulation of angiogenesis by ETS transcription factors
RANDI, A. M., Sperone, A., Dryden, N. H., & Birdsey, G. M. (2009) · Biochemical Society Transactions · doi:10.1042/bst0371248 · Cited by 84
Selvaraj, N., Kedage, V., & Hollenhorst, P. C. (2015) · Cell Communication and Signaling · doi:10.1186/s12964-015-0089-7 · Cited by 89
Self-citationThe impact of Fli1 deficiency on the pathogenesis of systemic sclerosis
Asano, Y., Bujor, A. M., & Trojanowska, M. (2010) · Journal of Dermatological Science · doi:10.1016/j.jdermsci.2010.06.008 · Cited by 85
Nagai, N., Ohguchi, H., Nakaki, R., Matsumura, Y., Kanki, Y., Sakai, J., Aburatani, H., & Minami, T. (2018) · PLOS Genetics · doi:10.1371/journal.pgen.1007826 · Cited by 75
Ets2 is required for trophoblast stem cell self-renewal
Wen, F., Tynan, J. A., Ceceña, G., Williams, R. M., Múnera, J. O., Mavrothalassitis, G., & Oshima, R. G. (2007) · Developmental Biology · doi:10.1016/j.ydbio.2007.09.024 · Cited by 73
Khanna, A., Okkeri, J., Bilgen, T., Tiirikka, T., Vihinen, M., Visakorpi, T., & Westermarck, J. (2011) · PLoS ONE · doi:10.1371/journal.pone.0017979 · Cited by 67
Asano, Y., & Trojanowska, M. (2009) · Molecular and Cellular Biology · doi:10.1128/mcb.01320-08 · Cited by 73
Injury-Mediated Vascular Regeneration Requires Endothelial ER71/ETV2
Park, C., Lee, T., Bhang, S. H., Liu, F., Nakamura, R. E. I., Oladipupo, S. S., Pitha, I., Capoccia, B. J., Choi, H. S., Kim, T., et al. (2015) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.115.306430 · Cited by 68
ETS Transcription Factors in Embryonic Vascular Development
Craig, M. P., & Sumanas, S. (2016) · Angiogenesis · doi:10.1007/s10456-016-9511-z · Cited by 56
Dryden, N. H., Sperone, A., Martin-Almedina, S., Hannah, R. L., Birdsey, G. M., Khan, S. T., Layhadi, J. A., Mason, J. C., Haskard, D. O., Göttgens, B., et al. (2012) · Journal of Biological Chemistry · doi:10.1074/jbc.m112.346791 · Cited by 65
Zhang, J. S., König, A. O., Harrison, A. M., Ugolkov, A. V., Fernández-Zapico, M. E., Couch, F. J., & Billadeau, D. D. (2011) · Oncogene · doi:10.1038/onc.2011.90 · Cited by 69
ETS-dependent regulation of a distal Gata4 cardiac enhancer
Schachterle, W., Rojas, A., Xu, S.-M., & Black, B. L. (2012) · Developmental Biology · doi:10.1016/j.ydbio.2011.10.023 · Cited by 64
Hollenhorst, P. C., Paul, L., Ferris, M. W., & Graves, B. J. (2010) · Genes & Cancer · doi:10.1177/1947601910395578 · Cited by 62
“The cell cycle and cell proliferation genes affected by ETV4 knockdown in PC3 cells are either direct or indirect targets of ETV4.”
BackgroundMethodSelf-citationThe ETS Factor, ETV2: a Master Regulator for Vascular Endothelial Cell Development
Oh, S.-Y., Kim, J. Y., & Park, C. (2015) · Molecules and Cells · doi:10.14348/molcells.2015.0331 · Cited by 74
Integrin-linked kinase as a target for ERG-mediated invasive properties in prostate cancer models
Becker‐Santos, D. D., Guo, Y., Ghaffari, M., Vickers, E. D., Lehman, M., Altamirano-Dimas, M., Oloumi, A., Furukawa, J., Sharma, M., Wang, Y. Z., et al. (2012) · Carcinogenesis · doi:10.1093/carcin/bgs285 · Cited by 66
Cooperative DNA Binding with AP-1 Proteins Is Required for Transformation by EWS-Ets Fusion Proteins
Kim, S., Denny, C. T., & Wisdom, R. (2006) · Molecular and Cellular Biology · doi:10.1128/mcb.26.7.2467-2478.2006 · Cited by 68
Turner, D. P., & Watson, D. K. (2007) · Expert Review of Anticancer Therapy · doi:10.1586/14737140.8.1.33 · Cited by 72
Sharma, N. L., Massie, C. E., Butter, F., Mann, M., Bon, H., Ramos‐Montoya, A., Menon, S., Stark, R., Lamb, A. D. G., Scott, H. E., et al. (2014) · Nucleic Acids Research · doi:10.1093/nar/gku281 · Cited by 60
The importance of non-nuclear AR signaling in prostate cancer progression and therapeutic resistance
Zarif, J. C., & Miranti, C. K. (2016) · Cellular Signalling · doi:10.1016/j.cellsig.2016.01.013 · Cited by 62
Tomar, S., Plotnik, J. P., Haley, J., Scantland, J., Dasari, S., Sheikh, Z., Emerson, R. E., Lenz, D. L., Hollenhorst, P. C., & Mitra, A. K. (2017) · Cancer Letters · doi:10.1016/j.canlet.2017.11.012 · Cited by 56
Self-citationSalanga, M. C., Meadows, S. M., Myers, C. T., & Krieg, P. A. (2010) · Developmental Dynamics · doi:10.1002/dvdy.22277 · Cited by 52
Defining ETS transcription regulatory networks and their contribution to breast cancer progression
Turner, D. P., Findlay, V. J., Moussa, O., & Watson, D. K. (2007) · Journal of Cellular Biochemistry · doi:10.1002/jcb.21494 · Cited by 55
Kazerounian, S., Gerald, D., Huang, M., Chin, Y. R., Udayakumar, D., Zheng, N., O’Donnell, R. K., Perruzzi, C. A., Mangiante, L., Pourat, J., et al. (2012) · Cancer Research · doi:10.1158/0008-5472.can-11-3055 · Cited by 58
Costello, P. S., Nicolas, R. H., Willoughby, J. E., Wasylyk, B., Nordheim, A., & Treisman, R. (2010) · The Journal of Immunology · doi:10.4049/jimmunol.1000472 · Cited by 53
ETS-4 Is a Transcriptional Regulator of Life Span in Caenorhabditis elegans
Thyagarajan, B., Blaszczak, A. G., Chandler, K. J., Watts, J. L., Johnson, W. E., & Graves, B. J. (2010) · PLoS Genetics · doi:10.1371/journal.pgen.1001125 · Cited by 51
Cui, M., Zhao, Y., Hance, K. W., Shao, A. E., Wood, R. J., & Fleet, J. C. (2008) · Journal of Cellular Physiology · doi:10.1002/jcp.21657 · Cited by 54
Regulatory mechanisms of Robo4 and their effects on angiogenesis
Dai, C., Gong, Q., Cheng, Y., & Su, G. (2019) · Bioscience Reports · doi:10.1042/bsr20190513 · Cited by 59
ETS transcription factors and prostate cancer: The role of the family prototype ETS-1 (Review)
Wernert, N. (2012) · International Journal of Oncology · doi:10.3892/ijo.2012.1380 · Cited by 49
Kedage, V., Selvaraj, N., Nicholas, T. R., Budka, J. A., Plotnik, J. P., Jerde, T. J., & Hollenhorst, P. C. (2016) · Cell Reports · doi:10.1016/j.celrep.2016.10.001 · Cited by 56
Self-citationThe ets-Related Transcription Factor GABP Directs Bidirectional Transcription
Collins, P. J., Kobayashi, Y., Nguyen, L., Trinklein, N. D., & Myers, R. (2007) · PLoS Genetics · doi:10.1371/journal.pgen.0030208 · Cited by 53
Ets transcription factors in intestinal morphogenesis, homeostasis and disease.
Jedlicka, P., & Gutierrez‐Hartmann, A. (2008) · PubMed · doi:10.14670/hh-23.1417 · Cited by 45
Peghaire, C. R., Dufton, N., Lang, M., Salles‐Crawley, I. I., Ahnström, J., Kalna, V., Raimondi, C., Pericleous, C., Inuabasi, L., Kiseleva, R. Y., et al. (2019) · Nature Communications · doi:10.1038/s41467-019-12897-w · Cited by 47
Oncogenic ETS Factors in Prostate Cancer
Nicholas, T. R., Strittmatter, B. G., & Hollenhorst, P. C. (2019) · Advances in experimental medicine and biology · doi:10.1007/978-3-030-32656-2_18 · Cited by 58
Self-citationTranscriptional Repressor Erf Determines Extraembryonic Ectoderm Differentiation
Papadaki, C., Alexiou, M. V., Ceceña, G., Verykokakis, M., Bilitou, A., Cross, J. C., Oshima, R. G., & Mavrothalassitis, G. (2007) · Molecular and Cellular Biology · doi:10.1128/mcb.02237-06 · Cited by 55
Microsatellites are EWS/FLI response elements: Genomic "junk" is EWS/FLI's treasure
Gangwal, K., & Lessnick, S. L. (2008) · Cell Cycle · doi:10.4161/cc.7.20.6892 · Cited by 45
RAS/ERK pathway transcriptional regulation through ETS/AP-1 binding sites
Hollenhorst, P. C. (2012) · Small GTPases · doi:10.4161/sgtp.19630 · Cited by 52
Self-citationBoros, J., O’Donnell, A., Donaldson, I. J., Kasza, A., Zeef, L., & Sharrocks, A. D. (2009) · Nucleic Acids Research · doi:10.1093/nar/gkp804 · Cited by 42
“The latter two conditions result in ERK MAP kinase pathway activation, which is a known upstream regulator of Elk-1 activity (3,4,11).”
BackgroundWaardenberg, A. J., Maya, B., Bouveret, R., & Harvey, R. P. (2015) · BMC Bioinformatics · doi:10.1186/s12859-015-0701-2 · Cited by 41
Past, Current, and Future Strategies to Target ERG Fusion-Positive Prostate Cancer
Lorenzin, F., & Demichelis, F. (2022) · Cancers · doi:10.3390/cancers14051118 · Cited by 44
Selvaraj, N., Budka, J. A., Ferris, M. W., Jerde, T. J., & Hollenhorst, P. C. (2014) · Molecular Cancer · doi:10.1186/1476-4598-13-61 · Cited by 46
Self-citationETS‐targeted therapy: can it substitute for MEK inhibitors?
Tetsu, O., & McCormick, F. P. (2017) · Clinical and Translational Medicine · doi:10.1186/s40169-017-0147-4 · Cited by 45
Key Transcriptional Regulators of Early Vascular Development
Val, S. D. (2011) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.110.221168 · Cited by 50
Singh, A. K., Manickavinayaham, S., & Kumar, V. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.m111.238238 · Cited by 36
Pinte, S., Caëtano, B., Bras, A. L., Havet, C., Villain, G., Dernayka, R., Duez, C., Mattot, V., & Soncin, F. (2016) · Journal of Biological Chemistry · doi:10.1074/jbc.m116.731331 · Cited by 41
Seuter, S., Neme, A., & Carlberg, C. (2017) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/j.jsbmb.2017.08.006 · Cited by 36
ELK3 Suppresses Angiogenesis by Inhibiting the Transcriptional Activity of ETS-1 on MT1-MMP
Heo, S., & Cho, J. (2014) · International Journal of Biological Sciences · doi:10.7150/ijbs.8095 · Cited by 37
John, S. A., Russell, L., Chin, S. S., Luo, W., Oshima, R. G., & Garrett‐Sinha, L. A. (2014) · Molecular and Cellular Biology · doi:10.1128/mcb.00612-13 · Cited by 35
Animal Models of Scleroderma: Current State and Recent Development
Asano, Y., & Sato, S. (2013) · Current Rheumatology Reports · doi:10.1007/s11926-013-0382-7 · Cited by 39
Choi, Y. S., & Sinha, S. (2006) · Biochemical Journal · doi:10.1042/bj20060375 · Cited by 32
“... and cellular responses including tumorigenesis and differentiation [1,2].TheEtsfamilyisquitelarge,consistingofatleast26unique members in mouse, all of which contain an evolutionarily conserved DBD (DNA-binding domain) called the ETS ( Et wentysix)domain.Etsproteinsareexpressedinawidevarietyoftissues and organs and…”
BackgroundMesquita, D., Barros-Silva, J. D., Santos, J., Skotheim, R. I., Lothe, R. A., Paulo, P., & Teixeira, M. R. (2015) · Oncotarget · doi:10.18632/oncotarget.2847 · Cited by 38
Guan, F. H. X., Bailey, C. G., Metierre, C., O’Young, P., Gao, D., Khoo, T. L., Holst, J., & Rasko, J. E. J. (2017) · Journal of Hematology & Oncology · doi:10.1186/s13045-017-0446-7 · Cited by 37
Asano, Y. (2015) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2015.06.004 · Cited by 32
Post-transcriptional mechanisms contribute to Etv2 repression during vascular development
Moore, J. C., Sheppard-Tindell, S., Shestopalov, I. A., Yamazoe, S., Chen, J., & Lawson, N. D. (2013) · Developmental Biology · doi:10.1016/j.ydbio.2013.08.028 · Cited by 35
Budka, J. A., Ferris, M. W., Capone, M. J., & Hollenhorst, P. C. (2018) · Genes & Cancer · doi:10.18632/genesandcancer.182 · Cited by 30
Self-citationETV2/ER71, the key factor leading the paths to vascular regeneration and angiogenic reprogramming
Kim, T. M., Lee, R. H., Kim, M. S., Lewis, C. A., & Park, C. (2023) · Stem Cell Research & Therapy · doi:10.1186/s13287-023-03267-x · Cited by 38
Sloan, K. A., Marquez, H. A., Li, J., Cao, Y. X., Hinds, A., O’Hara, C., Kathuria, S., Ramirez, M. I., Williams, M. C., & Kathuria, H. (2009) · Carcinogenesis · doi:10.1093/carcin/bgp129 · Cited by 29
Metadata
- Authors
- Hollenhorst, P. C.
- Affiliations
- University of Utah (US)
- Corresponding author
- Hollenhorst, P. C.
- ORCID
- Hollenhorst, P. C.
- Venue
- Nucleic Acids Research
- Publisher
- Oxford University Press (OUP)
- Published
- 2004-10-11
- Volume
- 32
- Issue
- 18
- Pages
- 5693-5702
- ISSN
- 0305-1048 (ISSN-L)
- 1362-4962
- PMC
- PMC524310
- OpenAlex
- W2113086329
- Cited by
- 214
- References
- 89
- Citations by year
- 2026: 2 · 2025: 6 · 2024: 3 · 2023: 7 · 2022: 2 · 2021: 5 · 2020: 5 · 2019: 6 · 2018: 10 · 2017: 12 · 2016: 14 · 2015: 16 · 2014: 7 · 2013: 12 · 2012: 16
- FWCI
- 3.32
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- Nucleic Acids Research (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Cancer Institute (CA24014, T32CA093247, T32 CA 93247, P30CA042014)
- National Institute of General Medical Sciences (GM 38663, R01GM038663)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Genomics and Chromatin Dynamics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Developmental Biology and Gene Regulation
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Endocrinology › Estrogen and related hormone effects
- Keywords
- ETS transcription factors, promoter specificity, gene expression profiling, mRNA levels, paralogs, DNA binding specificity, tissue-specific gene expression, cell growth and differentiation, cancer mutations
- MeSH terms
- Binding Sites, Cell Line, DNA, DNA-Binding Proteins, Humans, Promoter Regions, Genetic, Proto-Oncogene Proteins, RNA, Messenger, Transcription Factors, Reverse Transcriptase Polymerase Chain Reaction, Gene Expression Profiling, Proto-Oncogene Proteins c-ets
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.